TORONTO, Jan. 30, 2024 /CNW/ - The team at RBC iShares, led by Helen Hayes, Head of iShares Canada, BlackRock and Mark Neill, Managing Director and Head of RBC ETFs & Strategic Alliances at RBC Global Asset Management Inc., joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market and celebrate the fifth year of the RBC iShares alliance.
RBC iShares ETFs are comprised of RBC ETFs managed by RBC Global Asset Management Inc. and iShares ETFs managed by BlackRock Asset Management Canada Limited. RBC iShares is a strategic alliance formed in 2019 between RBC Global Asset Management and BlackRock Canada. RBC iShares provides the largest suite of ETFs to Canadians, and leverages the combined investment expertise of Canada's largest asset manager and the world's largest ETF provider to help advisors build efficient portfolios that meet the needs of their clients.
CNW sponsored announcement. To learn more visit www.newswire.ca.
SAP SE today announced NEC Corporation (TSE: 6701 "NEC") has selected SAP S/4HANA Cloud through the RISE with SAP solution, running on Amazon Web Services (AWS). Together with implementation partner ABeam Consulting, the migration will leverage...
Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market....
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. ...
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide.
After more than 22 years of successful...
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...
